A recent proteogenomic analysis of HBV-related HCC in China indicated an impaired liver-specific metabolic function in HCC cells and downregulation of ALDH1B1, ALDH2, and ALDH3B1 92. This evidence concerns the gene ALDH3B1 and hepatocellular carcinoma.